Cell-derived microparticles: A mediator of inflammation in aortic valve stenosis?

Yeon S. Ahn; Wenche Jy; Laurence L. Horstman; Joaquin J. Jimenez

doi:10.1160/TH08-03-0135

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2008; 99(04): 657-658
DOI: 10.1160/TH08-03-0135

Editorial Focus

Schattauer GmbH

Cell-derived microparticles: A mediator of inflammation in aortic valve stenosis?

Authors

Yeon S. Ahn

¹Wallace Coulter Platelet Laboratory, Miller School of Medicine, University of Miami, Miami, Florida, USA
Wenche Jy

¹Wallace Coulter Platelet Laboratory, Miller School of Medicine, University of Miami, Miami, Florida, USA
Laurence L. Horstman

¹Wallace Coulter Platelet Laboratory, Miller School of Medicine, University of Miami, Miami, Florida, USA
Joaquin J. Jimenez

¹Wallace Coulter Platelet Laboratory, Miller School of Medicine, University of Miami, Miami, Florida, USA

Abstract

Full Text

References

References
1 Braunwald E. Aortic stenosis. Harrison’s Principles of Internal Medicine.. 16th Ed. New York, NY: McGraw Hill; 2005: 1396.
2 Rajamannan N, Otto CM. Targeted therapy to prevent progresion of calcified aortic stenosis. Circulation 2004; 110: 1180-1182.
3 Galant A. et al. C-reactiveprotein is increased in patients with degenerative aortic valve stenosis. J Am Coll Cardiol 2001; 38: 1078-1082.
4 Mazzone A. et al. Biological features (inflammation and neoangiogenesis) and atherosclerotic risk factors in carotid plaques and calcified aortic valve stenosis: teo different sites of the same disease?. Am J Clin Pathol 2006; 126: 494-502.
5 Diehl P. et al. Increased levels of circulating microparticles in patients with severe aortic valve stenosis. Thromb Haemost 2008; 99: 711-719.
6 Horstman LL. et al. Endothelial microparticles as markers of endothelial dysfunction. Frontiers in Bioscience 2004; 9: 1118-1135.
7 Miyazaki Y. et al. High shear stress can initate both platelet aggregation and shedding of procoagulant containing microparticles. Blood 1996; 88: 3456-3464.
8 Nomura S. et al. High shear stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells. Atheroscler 2001; 158: 277-287.
9 Pontiggia L. et al. Platelet microparticle formation and thrombin generation under high shear are effectively suppressed by a monoclonal antibody against GPIba. Thromb Haemost 2006; 96: 774-780.
10 Jy W. et al. Platelet microparticles bind, activate and aggregate neutrophils in vitro. Blood Cells Mol Dis 1995; 21: 217-231.
11 Barry OP. et al. Platelet microparticles enhance adhesive interactions between monocytes and endothelial cells. J Clin Invest 1997; 45: 271A.
12 Amirkhosravi A. et al. Platelet microparticles upregulate TF and VEGF in endothelial and melanoma cells in a CD40 ligand-dependent manner: Possible role in angiogenesis and metastasis. Blood 2002; 100: 63b.
13 Boulanger CM. et al. In vivo shear stress determines circulating levels of endothelial microparticles in end-stage renal disease. Hypertension 2007; 49: 902-908.
14 Jy W. et al. Interaction of endothelial microparticles (EMP) with leukocytes: potential roles of EMP in thrombosis and inflammation. Blood 2001; 98: 226a.
15 Sabatier F. et al. Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity. Blood 2002; 99: 3962-3970.
16 Jy W. et al. Endothelial microparticles (EMP) bind and activate monocytes: Elevated EMP-monocyte complexes in multiple sclerosis. Frontiers Biosci 2004; 9: 3137-3144.
17 Jimenez JJ. et al. Elevated endothelial microparticle-monocyte complexes induced by multiple sclerosis plasma and the inhibitory effects of interferon-beta 1b on release of endothelial microparticles, formation and transendothelial migration of monocyte-endothelial microparticle complexes. Mult Scler 2005; 11: 310-315.
18 Brodsky SV. et al. Endothelium-derived microparticles impair endothelial function in vitro. Am J Physiol Heart Circ Physiol 2004; 286: H1910-H1915.
19 Van Wijk MJ. et al. Isolated microparticles, but not whole plasma, from women with preeclampsia impair endothelium-dependent relaxation in isolated myometrial arteries from healthy pregnant women. Am J Obstet Gynecol 2002; 187: 1686-1693.
20 Boulanger CM. et al. Circulating microparticles from patients with myocardial infarctions cause endothelial dysfunction. Circulation 2001; 104: 2649-2652.
21 Mesri M, Altieri DC. Endothelial cell activation by leukocyte microparticles. J Immunol 1998; 161: 4382-4387.
22 Mesri M, Altieri DC. Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor production in a JNK1 signalling pathway. J Biol Chem 1999; 274: 23111-23118.
23 Fukushima S. et al. A novel strategy for myocardial protection by combined antibody therapy inhibiting both P-selectin and intercellular adhesion molecule-1via retrograde intracoronary route. Circulation 2006; 114: 251-256.
24 Rychly J, Nebe B. Therapeutic strategies in autoimmune diseases by interfering with leukocyte endothelium interaction. Curr Pharm Des 2006; 12: 3799-3806.
25 Kieseir BC. et al. Treatment and treatment trials inmultiple sclerosis. Curr Opin Neurol 2007; 20: 286-293.
26 Nakamura K. et al. Novel strategies for the treatment of inflammatory bowel disease: selective inhibition of cytokines and adhesion molecules. World J Gastroenterol 2006; 12: 4628-4635.
27 Flaumenhaft R. Formation and fate of platelet microparticles. Blood Cells Mol Dis 2006; 36: 182-187.
28 O’Connell DJ. et al. Phosphatidylinositol 4,5-bisphosphate regulates activation-induced platelet microparticle formation. Biochem 2005; 44: 6361-6370.
29 Abid-Hussein MN. et al. Inhibition of microparticle release triggers endothelial cell apoptosis and detachment. Thromb Haemost 2007; 98: 1096-1107.
30 Liebe V. et al. Statin therapy of calcific aortic stenosis: hype or hope?. Eur Heart J 2006; 27: 773-778.
31 Cowell SJ. et al. A randomised trial of intensive lipid-lowering therapy in calcific aortic stenosis. New Engl J Med 2005; 352: 2389-2397.
32 Tramontano AF. et al. Statin decreases endothelial microparticle release from human coronary artery endothelial cells: implication for the Rho-kinase pathway. Biochem Biophys Res Com 2004; 320: 34-38.
33 Tesselaar ME. et al. Microparticle-associated tissue factor activity: a link between cancer and thrombosis?. J Thromb Haemost 2007; 5: 520-527.
34 Tilley RE. et al. Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients. Thromb Res. 2008 epub Feb. 8, 2008.
35 Langer F. et al. Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intracvascular coagulation. Ann Hematol. 2008 epub Feb. 22 2008
36 Bidot L. et al. Recurrent thrombosis is frequently associated with increased microparticle-mediated thrombin generation. Blood 2006; 108: 427a.
37 Horstman LL. et al. Cell-derived microparticles in ischemic cerebrovascular disorders. Int J Neurol. 2008 in press.
38 Moura LM. et al. New understanding about calcific aortic stenosis and opportunities for pharmacologic intervention. Curr Opin Cardiol 2007; 22: 572-577.
39 Helske S. et al. Aortic valve stenosis: an active atheroinflammatory process. Curr Opin Lipidol 2007; 18: 483-491.